Celltrion Healthcare Co., Ltd.
091990
Rangering i aksjer
#2133
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
Aksjekurs
$57.75
Sist synkronisert: 2024-01-11
Markedsverdi
$9.42B
Endring (1 dag)
-0.25%
Endring (1 år)
0.00%
Land
KR
Handel Celltrion Healthcare Co., Ltd. (091990)
Kategori
Healthcare
Utbyttehistorikk for Celltrion Healthcare Co., Ltd. (091990)
Celltrion Healthcare Co., Ltd. (aksjesymbol: 091990) har gitt totalt 1 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $130.00
Utbytteavkastning (TTM): 0.0017
Summen av alle utbytter (justert for aksjesplitt): $130.00
Utbytteavkastning (TTM): 0.0017
Utbyttebetalinger for Celltrion Healthcare Co., Ltd. (091990) fra 2022 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $130.00 | 0.00% |
| 2022 | $130.00 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $135.20 | 0.00% |
| 2022 | $135.20 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
